1T3.STU Syndax Pharmaceuticals Inc

- EUR
Market cap
-
P/E
-
P/B
80.29x
ROE
-1,219.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 1T3.STU undervalued?

Graham number

The Graham number of Syndax Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Syndax Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Syndax Pharmaceuticals Inc yet.

Syndax Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.